Clinical Trials Directory

Trials / Completed

CompletedNCT06591455

A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis

A Single Center, Randomized Controlled, Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Han Ying · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study is a prospective, single center, randomized controlled, exploratory clinical trial aimed at evaluating the efficacy and safety of fenofibrate in newly diagnosed PBC subjects.

Conditions

Interventions

TypeNameDescription
DRUGFenofibrateFenofibrate 200mg/day
DRUGUDCA (Ursodeoxycholic acid)UDCA 13-15mg/kg/day

Timeline

Start date
2024-09-14
Primary completion
2025-08-18
Completion
2025-08-18
First posted
2024-09-19
Last updated
2025-11-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06591455. Inclusion in this directory is not an endorsement.

A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis (NCT06591455) · Clinical Trials Directory